Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Cancer Biotherapy & Radiopharmaceuticals|May 15, 2024
GSK-3: An "Ace" Among KinasesTheodore Lemuel MathuramDrug Research|February 2, 2018
GSK-3 Inhibitors: A Double-Edged Sword? - An Update on TideglusibTheodore Lemuel Mathuram, Lisa M Reece, Kotturathu Mammen CherianBiotechnology Letters|April 3, 2020
The apoptotic effect of GSK-3 inhibitors: BIO and CHIR 98014 on H1975 lung cancer cells through ROS generation and mitochondrial dysfunctionTheodore Lemuel Mathuram, Thiagarajan Venkatesan, Jayanta Das, et al.Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|February 13, 2018
Correlative Studies Unravelling the Possible Mechanism of Cell Death in Tideglusib-Treated Human Ovarian Teratocarcinoma-Derived PA-1 CellsTheodore Lemuel Mathuram, Vilwanathan Ravikumar, Lisa M Reece, et al.Environmental Toxicology and Pharmacology|August 5, 2016
Tideglusib induces apoptosis in human neuroblastoma IMR32 cells, provoking sub-G0/G1 accumulation and ROS generationTheodore Lemuel Mathuram, Vilwanathan Ravikumar, Lisa M Reece, et al.Biotechnology Letters|November 9, 2017
Copper oxide nanoparticles induce anticancer activity in A549 lung cancer cells by inhibition of histone deacetylaseArunachalam Kalaiarasi, Renu Sankar, Chidambaram Anusha, et al.Frontiers in Pharmacology|November 17, 2022
REV-ERB is essential in cardiac fibroblasts homeostasisXiaokang Luo, Shiyang Song, Lei Qi, et al.Pageof 1